Company profile
Treace Medical Concepts, Inc.
NASDAQ: TMCI · Healthcare · Medical - Devices
PublicHQ Ponte Vedra, FLCIK 0001630627Reports USD
#287 of 1,418 Healthcare companies by revenue45th-percentile growth
EA Score
55CFH 56DQ 52GM 59SS 58
v0.1 · 65/100 weight · provisional
↑ workforce scale, filing timeliness · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$205.3M
Rev growth YoY (TTM)
-4.0%
Net income (FY)
-$59.0M
Employees
450
as of 2026-08-13
Market cap
$308.1M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$212.7M$212.7M2025
Net income-$59.0M-$59.0M2025
Operating income-$54.2M-$54.2M2025
Total assets$190.6M$190.6M2025
Liabilities$103.2M$103.2M2025
Equity$87.3M$87.3M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Treace Medical Concepts, Inc.’s revenue?
Treace Medical Concepts, Inc. booked $212.7M in FY2025 revenue, growing 1.6% year over year — about the middle of the pack among Healthcare companies we track, at a -27.7% net margin.
Peers · Healthcare
AxoGen, Inc.80B+IDEAYA Biosciences, Inc.67BVanda Pharmaceuticals Inc.63CEstablishment Labs Holdings Inc.59CCanopy Growth Corporation59CCytek Biosciences, Inc.58CKey facts
CEOJohn T. Treace
SectorHealthcare
IndustryMedical - Devices
HeadquartersPonte Vedra, FL
ExchangeNASDAQ: TMCI
Employees450
IPO date2021-04-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.